JP2003292492A5 - - Google Patents

Download PDF

Info

Publication number
JP2003292492A5
JP2003292492A5 JP2003020506A JP2003020506A JP2003292492A5 JP 2003292492 A5 JP2003292492 A5 JP 2003292492A5 JP 2003020506 A JP2003020506 A JP 2003020506A JP 2003020506 A JP2003020506 A JP 2003020506A JP 2003292492 A5 JP2003292492 A5 JP 2003292492A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
optionally
hydrogen atom
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003020506A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003292492A (ja
JP5072166B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003020506A priority Critical patent/JP5072166B2/ja
Priority claimed from JP2003020506A external-priority patent/JP5072166B2/ja
Publication of JP2003292492A publication Critical patent/JP2003292492A/ja
Publication of JP2003292492A5 publication Critical patent/JP2003292492A5/ja
Application granted granted Critical
Publication of JP5072166B2 publication Critical patent/JP5072166B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003020506A 2002-01-30 2003-01-29 チエノピリミジン化合物、その製造法および用途 Expired - Lifetime JP5072166B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003020506A JP5072166B2 (ja) 2002-01-30 2003-01-29 チエノピリミジン化合物、その製造法および用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2002022034 2002-01-30
JP2002022034 2002-01-30
JP2002-22034 2002-01-30
JP2003020506A JP5072166B2 (ja) 2002-01-30 2003-01-29 チエノピリミジン化合物、その製造法および用途

Publications (3)

Publication Number Publication Date
JP2003292492A JP2003292492A (ja) 2003-10-15
JP2003292492A5 true JP2003292492A5 (cg-RX-API-DMAC7.html) 2006-01-26
JP5072166B2 JP5072166B2 (ja) 2012-11-14

Family

ID=29253350

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003020506A Expired - Lifetime JP5072166B2 (ja) 2002-01-30 2003-01-29 チエノピリミジン化合物、その製造法および用途

Country Status (1)

Country Link
JP (1) JP5072166B2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008094846A (ja) * 2003-01-29 2008-04-24 Takeda Chem Ind Ltd チエノピリミジン化合物およびその用途
CN101153042A (zh) 2003-01-29 2008-04-02 武田药品工业株式会社 噻吩并嘧啶化合物及其用途
JPWO2006083005A1 (ja) * 2005-02-03 2008-06-26 武田薬品工業株式会社 縮合ピリミジン誘導体およびその用途
RU2674977C2 (ru) * 2013-10-30 2018-12-14 Шанхай Хэнжуй Фармасьютикал Ко., Лтд. Производные пиразолопиримидона или пирролотриазона, способ их получения и их фармацевтические применения
TWI744224B (zh) 2015-02-26 2021-11-01 日商武田藥品工業股份有限公司 固形製劑
AR106472A1 (es) * 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
BR112022023937A2 (pt) 2020-05-29 2022-12-27 Myovant Sciences Gmbh Formas de dosagem oral sólidas de combinação de antagonistas do hormônio liberador de gonadotropina
CN113717149A (zh) * 2021-09-29 2021-11-30 成都伊诺达博医药科技有限公司 一种瑞卢戈利关键中间体及其制备方法

Similar Documents

Publication Publication Date Title
CA2514407A1 (en) Thienopyrimidine compounds and use thereof
JP7317028B2 (ja) 抗ガン剤として有用な置換キナゾリン誘導体と置換ピリドピリミジン誘導体
US8232278B2 (en) Pyrido(3,2-D)pyrimidines and pharmaceutical compositions useful for treating hepatitis C
CN113474337A (zh) 作为fgfr抑制剂用于治疗癌症的7-((3,5-二甲氧基苯基)氨基)喹喔啉衍生物
JP2006516250A (ja) カスパーゼ活性化剤およびアポトーシス誘導物質としての3,5−二置換−[1,2,4]−オキサジアゾールおよびそれらの誘導体ならびにそれらの使用
JP2008525498A5 (cg-RX-API-DMAC7.html)
KR101045154B1 (ko) 치환된 아자인돌옥소아세틱 피페라진 유도체의 조성물 및항바이러스 활성
Tamayo et al. Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase
RU2015106787A (ru) Замещенные пирролы, активные в качестве ингибиторов киназ
JPWO2008001886A1 (ja) オーロラ(Aurora)阻害剤
JP2005529089A5 (cg-RX-API-DMAC7.html)
SG185690A1 (en) THE USE OF sGC STIMULATORS, sGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS (SSc).
WO2008045664A2 (en) Heterocyclic pde4 inhibitors as antiinflammatory agents
KR20160012196A (ko) 피라졸로피롤리딘 유도체 및 질환의 치료에서의 그의 용도
EP2646428A1 (en) Heterocyclic derivates preparation processes and medical uses thereof
EP2037924A2 (en) Bicyclic heteroaryl inhibitors of pde4
JP2000159672A (ja) 硝酸誘発耐性の処置剤
CN113754679B (zh) 取代的嘧啶二酮类化合物及其用途
ES2828951T3 (es) Profármacos de inhibidores de la transcriptasa inversa del VIH
JP2013501785A (ja) 結核阻害剤としてのピリミジン化合物
JP2009507758A5 (cg-RX-API-DMAC7.html)
RU2003115612A (ru) Производные амидоалкилпиперидинов и амидоалкилпиперазинов, пригодные для лечения нарушений нервной системы
JP2002523511A5 (cg-RX-API-DMAC7.html)
US20130123290A1 (en) Pyrimidylaminobenzamide Derivatives for Treatment of Neurofibromatosis
CA2927641C (en) Pyrazolopyrimidone or pyrrolotriazone derivatives, method of preparing same, and pharmaceutical applications thereof